Literature DB >> 18590612

Value of genetic models in understanding the cause and mechanisms of Parkinson's disease.

Darren J Moore1, Ted M Dawson.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized pathologically by the degeneration of nigrostriatal pathway dopaminergic neurons and other neuronal systems and the appearance of Lewy bodies that contain alpha-synuclein. PD is generally a sporadic disease, but a small proportion of cases have a clear genetic component. Mutations have been identified in six genes that clearly segregate with disease in rare families with PD. Transgenic, knockout, and virus-based models of disease have been developed in rodents to further understand how these genes contribute to the pathogenesis of PD. In general, these animal models recapitulate many key features of the disease, including derangements in dopaminergic synaptic transmission, selective neurodegeneration, neurochemical deficits, alpha-synuclein-positive neuropathology, and motor deficits. However, a genetic model with all or most of these pathogenic features has proved difficult to create. In this article, we discuss these mammalian genetic models of PD and what they have revealed about the cause and mechanisms of this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590612      PMCID: PMC4431569          DOI: 10.1007/s11910-008-0045-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  55 in total

1.  Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.

Authors:  Y Matsuoka; M Vila; S Lincoln; A McCormack; M Picciano; J LaFrancois; X Yu; D Dickson; W J Langston; E McGowan; M Farrer; J Hardy; K Duff; S Przedborski; D A Di Monte
Journal:  Neurobiol Dis       Date:  2001-06       Impact factor: 5.996

2.  Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice.

Authors:  Masaki Wakamatsu; Aiko Ishii; Shingo Iwata; Junko Sakagami; Yuriko Ukai; Mieko Ono; Daiji Kanbe; Shin-ichi Muramatsu; Kazuto Kobayashi; Takeshi Iwatsubo; Makoto Yoshimoto
Journal:  Neurobiol Aging       Date:  2006-12-14       Impact factor: 4.673

Review 3.  Parkinson's disease. Second of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

Review 4.  Lessons from Drosophila models of DJ-1 deficiency.

Authors:  Darren J Moore; Valina L Dawson; Ted M Dawson
Journal:  Sci Aging Knowledge Environ       Date:  2006-01-11

5.  Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

Authors:  George K Tofaris; Pablo Garcia Reitböck; Trevor Humby; Sarah L Lambourne; Mark O'Connell; Bernardino Ghetti; Helen Gossage; Piers C Emson; Lawrence S Wilkinson; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurosci       Date:  2006-04-12       Impact factor: 6.167

6.  DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase.

Authors:  Eva Andres-Mateos; Celine Perier; Li Zhang; Beatrice Blanchard-Fillion; Todd M Greco; Bobby Thomas; Han Seok Ko; Masayuki Sasaki; Harry Ischiropoulos; Serge Przedborski; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

Review 7.  Animal models of Parkinson's disease progression.

Authors:  Gloria E Meredith; Patricia K Sonsalla; Marie-Francoise Chesselet
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088

Review 8.  Alpha-synuclein and transgenic mouse models.

Authors:  Pierre-Olivier Fernagut; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2004-11       Impact factor: 5.996

9.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.

Authors:  Tohru Kitada; Antonio Pisani; Douglas R Porter; Hiroo Yamaguchi; Anne Tscherter; Giuseppina Martella; Paola Bonsi; Chen Zhang; Emmanuel N Pothos; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

10.  Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.

Authors:  Zhizhong Dong; Boris Ferger; Jean-Charles Paterna; Denise Vogel; Sven Furler; Maribel Osinde; Joram Feldon; Hansruedi Büeler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

View more
  23 in total

Review 1.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 2.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

3.  Autonomic dysfunction and plasticity in micturition reflexes in human α-synuclein mice.

Authors:  Robert W Hamill; John D Tompkins; Beatrice M Girard; Richard T Kershen; Rodney L Parsons; Margaret A Vizzard
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

Review 4.  Microglia in neurodegenerative disease.

Authors:  V Hugh Perry; James A R Nicoll; Clive Holmes
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

5.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

6.  Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons.

Authors:  João Paulo L Daher; Mingyao Ying; Rebecca Banerjee; Rebecca S McDonald; Myriam Dumas Hahn; Lichuan Yang; M Flint Beal; Bobby Thomas; Valina L Dawson; Ted M Dawson; Darren J Moore
Journal:  Mol Neurodegener       Date:  2009-07-24       Impact factor: 14.195

7.  Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons.

Authors:  Liviu Aron; Pontus Klein; Thu-Trang Pham; Edgar R Kramer; Wolfgang Wurst; Rüdiger Klein
Journal:  PLoS Biol       Date:  2010-04-06       Impact factor: 8.029

8.  Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments.

Authors:  Mark R Etherton; Cory A Blaiss; Craig M Powell; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

9.  Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance.

Authors:  Charles R Arthur; Stephanie L Morton; Lisa D Dunham; Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2009-09-23       Impact factor: 14.195

10.  PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs.

Authors:  Jin Ok Yang; Woo-Yeon Kim; So-Young Jeong; Jung-Hwa Oh; Sungwoong Jho; Jong Bhak; Nam-Soon Kim
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.